1. Home
  2. TECX vs DRTS Comparison

TECX vs DRTS Comparison

Compare TECX & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$19.63

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$5.09

Market Cap

300.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
DRTS
Founded
2019
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
300.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
DRTS
Price
$19.63
$5.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$81.20
$8.00
AVG Volume (30 Days)
350.0K
183.4K
Earning Date
11-06-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$2.30
52 Week High
$61.07
$5.21

Technical Indicators

Market Signals
Indicator
TECX
DRTS
Relative Strength Index (RSI) 52.23 65.52
Support Level $17.79 $4.72
Resistance Level $19.12 $5.21
Average True Range (ATR) 1.43 0.36
MACD -0.22 0.09
Stochastic Oscillator 48.25 87.73

Price Performance

Historical Comparison
TECX
DRTS

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: